biotech · Acute Myeloid Leukemia · Sarcoma,Soft Tissue · MBRX
Moleculin Biotech
Moleculin Biotech clinical programs — 2 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Houston, USA HQ
2006 Founded
22 Employees
Public company Type
MBRX · NYSE Ticker
Company details
- Status
- Public
- HQ
- Houston, USA
- Founded
- 2006
- Employees
- 22
- Programs
- 9
- Drugs
- 10
- Patents
- 1
Moleculin Biotech projects
2 ClinicalTrials.gov programs sponsored by Moleculin Biotech.
Moleculin Biotech has 2 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
Frequently asked questions
How many clinical projects does Moleculin Biotech have?
2 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.